Vertex Pharmaceuticals | Our Locations
Vertex Pharmaceuticals has research and development sites, manufacturing facilities, headquarters and regional offices around the world.
FDA approves painkiller designed to eliminate risks of addiction ...
Jan 30, 2025 · WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.. The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a …
Jan 30, 2025 · BOSTON--(BUSINESS WIRE)--Jan. 30, 2025-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to …
What to know about Journavx and MA-based Vertex Pharmaceuticals
Jan 31, 2025 · The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday.
FDA OK's painkiller designed to end opioids' addiction and …
Jan 31, 2025 · Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of ... Photo provided by Vertex Pharmaceuticals in January 2025 shows a tablet and ...
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk …
Jan 30, 2025 · Researchers say they expect it to be the first of a new generation of more powerful nonaddictive drugs to relieve pain. To test the drug, Vertex, which is based in Boston, conducted two large...
FDA approves Vertex non-opioid painkiller drug Journavx
Jan 30, 2025 · The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
Vertex Pharmaceuticals | Home
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases. We’re focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
Global Locations | Vertex Pharmaceuticals
Vertex has research and development sites and offices around the world. Additional information, including contact information for these sites, is available by clicking on the locations below. Additional Offices. Vertex Pharmaceuticals GmbH. Lehrbachgasse 13, 2. Stock. Av. Pres. Juscelino Kubitschek, 2041 - Complexo JK Torre E – Conj. A – 11th floor
FDA approves painkiller designed to eliminate addiction
Jan 31, 2025 · (Vertex Pharmaceuticals via AP) FDA approves painkiller designed to eliminate risk of addiction associated with opioids By Associated Press Washington, D.C.
- Some results have been removed